As Glaucoma Awareness Month highlights evolving practice, specialists describe how artificial intelligence, sustained drug ...
New Hampshire should insist that its citizens receive surgery from properly trained surgeons by asking legislators to reject ...
Joel S. Schuman, MD, FACS, highlights home tonometry, virtual visual fields, and portable OCT devices as promising tools, ...
I’m writing to share about a recent eye procedure I had that is relevant to Ohio Senate Bill 36, the primary eye care modernization bill our policymakers are currently debating. I underwent a ...
ViaLase Inc. announced that the first patient has been treated in an investigational device exemption (IDE) clinical trial ...
TO SEE THINGS THE WAY OF THE OPTOMETRISTS OR THE OPHTHALMOLOGISTS AT THE STATEHOUSE. IT IS A PUBLIC POLICY WAR, LARGELY INVISIBLE TO PATIENTS OR THE PUBLIC. BUT EYE DOCTORS HAVE BEEN LOCKED IN AN ...
ALISO VIEJO, Calif.--(BUSINESS WIRE)--ViaLase, Inc., a clinical-stage medical technology company pioneering incision-free, laser-based solutions for glaucoma, today announced that the first patient ...
CHICAGO -- Upfront laser trabeculoplasty significantly slowed glaucoma progression and vision loss as compared with eye drops, long-term follow-up from a large randomized trial showed. After 6 years ...
Glaucoma specialists may now be opting for selective laser trabeculoplasty instead of topical drops for treatment-naïve ocular hypertension and open-angle glaucoma. A majority of American glaucoma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback